NEW YORK, Nov 17 – Aurora Biosciences has acquired Panvera, a Madison, W isc. company that manufactures recombinant protein drug targets and protein drug screening assays, in a merger agreement announced Friday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genetic link between birth weight and adult-onset diseases, and more.
Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.
DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.
Researchers discuss the need for antibody standards at a meeting, NPR reports.